S100A9 and myocardial infarction: Furthermore, S100A9 plays a crucial role in the conversion of inflammatory monocytes into reparative macrophages in myocardial infarction models by upregulating the levels and activity of the transcription factor Nur77, which could be inhibited by ABR-238901 (or paquinimod, a specific S100A9 blocker)8.